免疫疗法:为治愈1型糖尿病打造桥梁
Jeffrey A Bluestone1, Jane H Buckner2,3, Kevan C Herold4
1UCSF Diabetes Center, University of California San Francisco, San Francisco, CA 94143, USA.
概括
一型糖尿病 (T1D) 涉及免疫细胞破坏胰岛素产生细胞. 最近的研究揭示了关键的疾病机制和新的免疫疗法来预防和治疗T1D,
科学领域:
- 免疫学
- 内分泌学
- 自身免疫性疾病
背景情况:
- 1型糖尿病 (T1D) 是一种自身免疫性疾病,其中T细胞破坏胰腺β细胞.
- 遗传和环境因素会破坏免疫平衡,增加T1D的风险.
- 目前的胰岛素治疗可以治疗T1D,但不能解决根本原因或预防所有并发症.
研究的目的:
- 审查T1D的胰腺小岛炎症发病和持续的主要事件.
- 总结目前的T1D免疫疗法.
- 在T1D治疗中讨论这些新疗法的优势.
主要方法:
- 本综述综合了有关T1D病变的当前研究.
- 它分析了各种免疫细胞和可溶性因子在β细胞破坏中的作用.
- 该审查审查了现有和新兴的免疫治疗策略.
主要成果:
- 多种免疫细胞类型和可溶性因子已被确定为beta细胞破坏的关键因素.
- 了解这些机制为开发有针对性的治疗铺平了道路.
- 免疫疗法旨在预防或修改T1D的自身免疫过程.
结论:
- 对T1D病变的洞察力导致了有前途的新疗法的开发.
- 免疫治疗有可能改变疾病的进程,而不仅仅是胰岛素替代.
- 进一步的研究和临床应用对于改善T1D治疗至关重要.
相关概念视频
Tumor Immunotherapy
778
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
778
Diabetes: Management and Pharmacotherapy
595
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
595
Diabetes Mellitus: Overview and Type I Subtype
4.0K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.0K
Insulin: Dosing Regimen and Adverse Effects
329
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
329
Cancer Vaccines
581
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
581
Diabetes Mellitus: Type 2 and Gestational
3.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.6K


